Nigerian neonatologists perception and experience with retinopathy of prematurity

Abstract

Background: Retinopathy of Prematurity (ROP) is an avoidable condition that affects premature infants exposed to oxygen stresses at or soon after birth. In low- and middle-income countries, like Nigeria, neonatal mortality rates are high and very few infants live to develop ROP. With recent better care, ROP is now being diagnosed.
Objective: This study aimed to characterize what Nigerian neonatologists understand about ROP. Methods: At a joint meeting of Nigerian pediatric ophthalmologists and neonatologists in Kebbi State held 26-29 July 2018, questionnaires collected attendees’ perspective and experience with ROP including causes, risk factors and experiences.
Results: Fifty-one neonatologists out of 71 returned a completed questionnaire (response rate: 71.8%). The male:female ratio was 1:1.8, and approximately 40% were aged 41-50 years (n=20, 39.22%). Only 3 (6.39%) had experience managing infants below 500g that survived. A majority managed babies with a mean weight of 913g ± 300.37 and age of 27.87 weeks ±2.37. Most had no access to oxygen monitors (n=39,78%). Most had 10 babies to one monitor and used average settings of 90- 95%. One third had seen a case of ROP (n=15,29.41%). Only 5.88% (n=3) were unaware of uncontrolled oxygen use as a risk factor. Only 4 (8.89%) had a functional screening team. None were aware of local screening guidelines.
Conclusions: Regular educational programs, collaborative clinical presentations and webinars about ROP targeted at the neonatologists and parents, including establishment of screening programs across country will likely help reduce the burden of ROP blindness in Nigeria.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

References

1.Gilbert CE, Foster A, Negrel AD, Thylefors B. Childhood blindness: a new form of recording causes of visual loss in children. Bull World Health Organ.1993;71(5)485-489.

2. Olitsky SE, Nelson LB,“Disorders of the eyes,”in Nelson Textbook of Pediatrics, R.E. Behrman, R.M. Kliegman,and H.B. Jenson, Eds., pp. 6588–6591, WB Saunders, Philadelphia, Pa,USA, 17th edition, 2003.

3. Adio AO, Ugwu RO, Nwokocha CG, Eneh AU. Retinopathy of Prematurity in Portharcourt, Nigeria. ISRN Ophthalmology.2014:481527.doi:1155.2014/481527.e collection 2014 PMID:24649375


4. Campbell K, “Intensive oxygen therapy as a possible cause for retrolental fibroplasia. A clinical approach,” Med J Australia ,vol.2,pp.48–50,1951.

5.Kretzerand FL, Hittner HM, “Retinopathy of prematurity: clinical implications of retinal development,” Arch Dis Childhood, vol. 63, no. 10, pp. 1151–1167, 1988.

6. Zin A, Gole GA. Retinopathy of prematurity-incidence today . Clin Perinatol. 2013: 40; 185-200.

7. Gilbert C. Retinopathy of prematurity: A global perspective of epidemics, population of babies at risk and implications for early control. Early Hum Dev. 2008; 84: 77-82.

8. Ademola-Popoola DS, Oluleye TS. 2019.Retinopathy of prematurity in a developing economy with improving health care. Curr Ophthalmol Rep DOI 10.1007/s40135-017-0129-0.

9.Solebo AL, Teoh L, Rahi J. Epidemiology of blindness in children. Arch Dis Child. 2017 Sep;102(9):853-857. doi: 10.1136/archdischild-2016-310532. Epub 2017 May 2.

9.Zepeda-Romero LC1, Barrera-de-Leon JC, Camacho-Choza C, Gonzalez Bernal C, Camarena-Garcia E, Diaz-Alatorre C, Gutierrez-Padilla JA, Gilbert C. Retinopathy of prematurity as a major cause of severe visual impairment and blindness in children in schools for the blind in Guadalajara city, Mexico. Br J Ophthalmol. 2011;95(11):1502-5. doi: 10.1136/bjophthalmol-2011-300015. Epub 2011 Jun 7.

10.Hariharan L, Gilbert CE, Quinn GE, Barg FK, Lomuto C, Quiroga A, McLeod- Omawale J, Zin A, Ortiz Z, Alda E, Bouzas L, Brussa M, Cattaino A, Dinerstein A, Erpen N, Fandiño A, Galina L, Manzitti J, Marinaro S, Sepúlveda T, Visintín P, Silva JC, Magluta C, Benitez A. Reducing Blindness from Retinopathy of Prematurity (ROP) in Argentina Through Collaboration, Advocacy and Policy Implementation. Health Policy Plan. 2018 Jun 1;33(5):654-665. doi: 10.1093/heapol/czy004.

11.Arnesen L, Durán P, Silva J, Brumana L.A multi-country, cross-sectional observational study of retinopathy of prematurity in Latin America and the Caribbean. Rev Panam Salud Publica. 2016 Jun;39(6):322-329.

12. Zin AA, Magluta C, Pinto MF, Entringer AP, Mendes-Gomes MA, Moreira ME, Gilbert C.
Retinopathy of prematurity screening and treatment cost in Brazil. Rev Panam Salud Publica. 2014 Jul;36(1):37-43.

13.Adekeye M. Causes of blindness in children in NE Nigeria: a blind school study [Dissertation for Masters degree in Community eye health, Department of Preventive Ophthalmology, Institute of Ophthalmology, London, UK, 1996.

14.Baiyeroju-Agbeja AM, Omokhodion F. Screening for retinopathy of prematurity. Nig J Ophthalmol 1998;6(1):23–25, 1998.

15.Oluleye TS, Rotimi-Samuel A, Adenekan A. Mobile phones for retinopathy of prematurity screening in Lagos, Nigeria, Sub-Saharan Africa. Eur J Ophthalmol 2016;26(1):92-94.doi:10.5301/ejo.50000666.Epub 2015 Sep 8.

16. Screening examination of premature infants for retinopathy of prematurity A joint statement of the American Academy of Pediatrics, the American Academy of Ophthalmology and American Association for Pediatric Ophthalmology. 2019

17. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1998; 106: 471–479.

18. Clemett R, Darlow B. Results of screening low-birth-weight infants for retinopathy of prematurity. Curr Opin Ophthalmol. 1999;10(3):155–163.

19. Rani P, Jalali S. Knowledge, attitude and practice study of retinopathy of prematurity amongst pediatricians attending a neonatal ventilation workshop in South India. World J of Retina & Vit. 2011; 1 (1): 9-13.

20. Agarwal K, Jalali S. Classification of retinopathy of prematurity: from then till now. Community eye health 2018;31(101):S4-S7.

21. Jalali S, Azad R. Community eye health. It is time to take swift action. 2018;31(101): S1-S2.

22. Akinyemi JO, Bamgboye EA, Ayeni O. Trends in neonatal mortality in Nigeria and effects of bio-demographic and maternal characteristics. BMC Pediatr 2015 Apr 9;15:36.doi:10.1186/s12887-015-0349-0.


23. Uhumwangho OM, Israel-Aina YT. Awareness and screening for retinopathy of prematurity among pediatricians in Nigeria. J West Afr Coll of Surgeons.2013; 3(3):33-45

24. Ademola-Popoola D, Adesiyun O, Durotoye IA, Obasa TO. West Afr J Med 2013; 32(4):281-285. Screening program for retinopathy of prematurity in Ilorin, Nigeria: a pilot study.

25. Fajolu IB, Rotimi-Samuel A, Aribaba OT, Musa KO, Akinsola FB, Ezeaka VC, Onakoya AO. retinopathy of prematurity and associated factors in Lagos, Nigeria. Peadiatr Int Child Health. 2015;35(4):324-328.doi10.1080/20469047.2015.1109277.

26 Gilbert C, Malik ANJ, Nahar N, Das SK, Visser L, Sitati S, Ademola-Popoola DS. Epidemiology of ROP update-Africa is the new frontier. Semin Perinatol 2019;43(6):317-322.doi:1053/j.semperi.2019.05.002.

27.Walker PJB, Bakare AA, Ayede AI, Oluwafemi RO, Olubosede OA, Olafimihan IV, Tan K, Duke T, Falade AG, Graham H. using intermittent pulse oximetry to guide neonatal oxygen therapy in a low-resource context. Arch Dis Child Fetal Neonatal Ed.2019.pii: fetalnonatal-2019-317630.doi10.1136/archdischil-2019-317630.

28. Bhattacharya AA, Allen E,Umar N,Usman AU, Felix H, Audu A, Schellenberg JR, Marchant T. Monitoring childbirth care in primary health facilities: a validity study in Gombe state, Northeastern Nigeria. J Glob Health.2019;9(2): 020411.doi:10.7189/jogh.09.020411.

29. Olukade T, Yaya S. Bishwajit G, Uthman OA. Sociodemographic determinants of post-caesarean neonatal mortality in Nigeria. J Obstet Gynaecol. 2019 29:1-7.doi:10.1080/01443615.2019.1627300.

30. Akombi BJ, Renzaho AM. Perinatal mortality in Sub-Saharan Africa: A meta-analysis of demographic and Health Surveys. Ann Glob Health.2019 12;85(1).pii:106.doi:10.5334.aogh.2348.

31. Farouk ZL, Muhammed A, Gambo S, Mukhtar-Yola M, Umar Abdullahi S, Slusher TM. Follow-up of children with kernicterus in Kano, Nigeria. J Trop Pediatr 2018 June 1;64(3): 176-182.doi::10.1093/tropej/fmx041.

32. Eneriz-Wiemer M, Liu SD, Chu MCY, Uribe-Leitz T, Rajani K, Sankar M, Robbins SL, Lee HC, Woodard C, Wang CJ. Parents’ knowledge and education of retinopathy of prematurity in four California neonatal intensive care units. 2018. Am J Ophthalm. 2018;191:7-13.doi:10.1016/j.ajo.2018.03.039.

33.Al-Khaled T, Mikhail M,Jonas KE, Wu WC, Anzures R, Amphonphruet A, Chuluunbat T, Wu L, Chiang MF, Campbell JP, Chan RVP; Global Education Network for Retinopathy of Prematurity(GEN-ROP). J Pediatr Ophthalmol Strabismus. 2019 Sep 1;56(5):282-287.doi:10.3928/01913913-20190717-01.

34.Chan RV, Patel SN, Ryan MC, Jonas KE, Ostmo S, Port AD, Sun GI, Lauer AK, Chiamg MF. The Global Education Network for Retinopathy of Prematurity(GEN-Rop): development, Impelementation and evaluation of a novel Tele-Education system(an American Ophthalmological thesis) Trans Am Ophthamol Soc 2015;113:T2

35.Shah PK, Prabhu V, […]Kalpana N. Retinopathy of prematurity: Past, present and future. World J Clin Pediatr 2016;5(1):35-46.
Published
2021-06-23
Info
Issue
Section
Original Articles
Keywords:
Retinopathy of prematurity, screening guidelines, oxygen, neonatologists, Nigeria
Statistics
  • Abstract views: 1222

  • PDF: 122
  • HTML: 0
How to Cite
Adio, A., Aliyu, S. S.-E., Balarabe, A. H., Monsudi, K., Popoola, D. A., & Lawal, T. (2021). Nigerian neonatologists perception and experience with retinopathy of prematurity. Journal of Public Health in Africa, 12(1). https://doi.org/10.4081/jphia.2021.1289